Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHansard Regulatory News (HSD)

Share Price Information for Hansard (HSD)

Share Price is delayed by 15 minutes
Get Live Data
53.50    1.00 (1.90%)
Bid:
49.40
Ask:
54.00
Spread: 4.60 (9.312%)
Market Cap: £73.05m
HSD Live PriceLast checked at - London Stock Exchange

Intraday Hansard Share Chart

Directorate Change

3 Jan 2012 12:02

RNS Number : 8962U
Hansard Global plc
03 January 2012
 



 

 

Hansard Global plc ("Hansard")

Directorate Change

 

 

Hansard announces that Mr Uwe Eymer has retired from the Board as a Non-Executive Director with effect from 31st December 2011.

 

Dr Leonard Polonsky, Executive Chairman, stated, "On behalf of the Board, I would like to take this opportunity to thank Uwe for his valuable contribution to Hansard from the time of its listing on the London Stock Exchange in December 2006 to date and wish him every success for the future".

 

For further information, please contact:

 

Hansard Global plc

Manoj B Patel, Company Secretary +44 (0)1624 688000

 

Pelham Bell Pottinger +44 (0)20 7861 3232

Daniel de Belder

 

 

Notes to Editors:

 

Hansard Global is a specialist long-term savings provider, based on the Isle of Man. The Company offers a range of flexible, tax-efficient investment products within a life assurance policy wrapper, developed to appeal to affluent international investors.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABBGDBRUGBGDX
Date   Source Headline
23rd Feb 20177:00 amRNSHalf-year Report
21st Feb 20176:08 pmRNSHolding(s) in Company
17th Feb 20174:40 pmRNSSecond Price Monitoring Extn
17th Feb 20174:35 pmRNSPrice Monitoring Extension
13th Feb 20174:40 pmRNSSecond Price Monitoring Extn
13th Feb 20174:35 pmRNSPrice Monitoring Extension
26th Jan 20177:00 amRNSNew Business Results
19th Jan 20177:00 amRNSStrategic Alliance in the UAE
17th Jan 201712:02 pmRNSPrice Monitoring Extension
11th Jan 20174:21 pmRNSHolding(s) in Company
5th Jan 20174:40 pmRNSSecond Price Monitoring Extn
5th Jan 20174:35 pmRNSPrice Monitoring Extension
4th Jan 20174:35 pmRNSPrice Monitoring Extension
13th Dec 20167:00 amRNSEmployee Benefit Trust Share Purchase
8th Dec 20164:35 pmRNSPrice Monitoring Extension
10th Nov 20167:00 amRNSTrading Update
9th Nov 20163:59 pmRNSAGM Statement
1st Nov 20164:35 pmRNSPrice Monitoring Extension
24th Oct 20167:00 amRNSBlock listing Interim Review
17th Oct 20165:41 pmRNSNotice of AGM
22nd Sep 20162:03 pmRNSDirector/PDMR Shareholding
22nd Sep 201612:07 pmRNSSecond Price Monitoring Extn
22nd Sep 201612:02 pmRNSPrice Monitoring Extension
22nd Sep 20167:00 amRNSFinal Results
26th Aug 20164:40 pmRNSSecond Price Monitoring Extn
26th Aug 20164:35 pmRNSPrice Monitoring Extension
28th Jul 20167:00 amRNSNew business results for year ended 30 June 2016
22nd Jul 20164:35 pmRNSPrice Monitoring Extension
7th Jul 20164:35 pmRNSPrice Monitoring Extension
13th Jun 20164:35 pmRNSPrice Monitoring Extension
12th May 20167:00 amRNSInterim Management Statement
22nd Apr 20167:00 amRNSBlock listing Interim Review
7th Apr 20163:24 pmRNSDirector/PDMR Shareholding
7th Apr 20163:21 pmRNSDirector/PDMR Shareholding
25th Feb 20167:00 amRNSResults for the six months ended 31 December 2015
28th Jan 20167:00 amRNSNew Business Results
14th Dec 201510:10 amRNSDirector/PDMR Shareholding
8th Dec 20157:00 amRNSDirector/PDMR Shareholding
2nd Dec 20153:59 pmRNSDirector/PDMR Shareholding
13th Nov 20152:04 pmRNSDirectorate Change
13th Nov 20157:00 amRNSInterim Management Statement
12th Nov 201511:38 amRNSAGM Statement
22nd Oct 201512:16 pmRNSBlocklisting Interim Review
2nd Oct 20159:12 amRNSDirector/PDMR Shareholding
24th Sep 20154:26 pmRNSFinal Dividend Declaration
23rd Sep 20151:13 pmRNSDirector/PDMR Shareholding
23rd Sep 20151:12 pmRNSDirector/PDMR Shareholding
23rd Sep 20157:00 amRNSResults for the year ended 30 June 2015
30th Jul 20157:00 amRNSNew business results - year ended 30 June 2015
21st Jul 20151:25 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.